Prospective Evaluation of Univentricular Hearts

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Nov 10, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the care and treatment of children with univentricular heart defects, which are complex heart problems that require multiple surgeries. The main goal is to evaluate a standardized treatment approach used in Erlangen, Germany, to help improve the outcomes for these patients as they undergo a series of operations, particularly the Fontan procedure. This procedure helps create a more effective way for blood to flow through the heart and body. Unfortunately, children with these conditions face higher risks of complications and even death before and shortly after the Fontan operation, so this trial aims to monitor their heart function and overall health closely.

To participate in the trial, children must have a univentricular heart defect and need the Fontan procedure as part of their treatment plan. There are no specific exclusions based on health conditions, meaning many children with this heart defect may be eligible. Families can expect regular check-ups that include advanced imaging tests to assess heart function and identify any potential issues early on. The researchers hope that by closely following these patients and using the structured treatment protocol, they can provide better care and improve long-term outcomes for children with univentricular heart defects.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • congenital heart defect of the univentricular type and the clinical necessity of a multi-stage treatment in terms of the Fontan procedure.
• Exclusion Criteria:
• • no exclusion criteria